300633 开立医疗
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-0.3566.1934.55415.44214.516
总资产报酬率 ROA (%)-0.2674.5253.52312.42411.267
投入资产回报率 ROIC (%)-0.3185.4374.14014.36013.229

边际利润分析
销售毛利率 (%)61.44261.98763.78367.71166.866
营业利润率 (%)-3.4977.1586.03622.39421.696
息税前利润/营业总收入 (%)0.8865.6864.11220.24119.973
净利润/营业总收入 (%)-2.4158.5447.07121.43320.980

收益指标分析
经营活动净收益/利润总额(%)254.97176.33899.87696.02389.845
价值变动净收益/利润总额(%)-1.8751.4373.462-2.7101.393
营业外收支净额/利润总额(%)-0.776-0.665-1.137-0.208-0.127

偿债能力分析
流动比率 (X)2.9572.7602.7464.6173.355
速动比率 (X)1.9732.0122.1433.6822.669
资产负债率 (%)24.09025.95927.93416.58422.697
带息债务/全部投入资本 (%)8.3958.14511.7511.8928.800
股东权益/带息债务 (%)1,064.8591,099.480731.7885,093.5281,016.020
股东权益/负债合计 (%)315.107285.228257.992502.980340.596
利息保障倍数 (X)0.203-3.989-2.215-9.606-11.778

营运能力分析
应收账款周转天数 (天)55.28939.94234.50531.65941.571
存货周转天数 (天)403.918290.539292.342274.978294.299